Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein in Low and High Grade B-Cell Non-Hodgkin Lymphomas and Differential Regulation of EZH2 Expression By p-ERK and MYC in High Grade B Cell Lymphomas

被引：0

作者：

Tian, Xuejun ^{[1
]}

Shahsafaei, Ali ^{[2
]}

Dorfman, David M. ^{[3
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Pathol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas
Tian, Xuejun
Pelton, Ashley
Shahsafaei, Ali
Dorfman, David M.
MODERN PATHOLOGY, 2016, 29 (09) : 1050 - 1057
[2] Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Low and High Grade B-Cell Non-Hodgkin Lymphomas
Tian, Xuejun
Shahsafaei, Ali
Dolfman, David M.
MODERN PATHOLOGY, 2016, 29 : 379A - 379A
[3] Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Low and High Grade B-Cell Non-Hodgkin Lymphomas
Tian, Xuejun
Shahsafaei, Ali
Dorfman, David M.
LABORATORY INVESTIGATION, 2016, 96 : 379A - 379A
[4] Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas
Tian, Xuejun
Xu, Jie
Dorfman, David M.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (01) : 102 - 109
[5] Enhancer of ZesteHomolog 2 (EZH2) Protein Is Differentially Expressed in B-Cell Non-Hodgkin Lymphomas and Hodgkin Lymphomas and Correates With Neoplastic Cell Proliferation Rate
Tian, Xuejun
Shahsafaei, Aliakbar
Dorfman, David
LABORATORY INVESTIGATION, 2015, 95 : 381A - 382A
[6] Enhancer of ZesteHomolog 2 (EZH2) Protein Is Differentially Expressed in B-Cell Non-Hodgkin Lymphomas and Hodgkin Lymphomas and Correates With Neoplastic Cell Proliferation Rate
Tian, Xuejun
Shahsafaei, Aliakbar
Dorfman, David
MODERN PATHOLOGY, 2015, 28 : 381A - 382A
[7] Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas
Zhou, Bin
Liang, Xiaofei
Mei, Husheng
Qi, Shuang
Jiang, Zongru
Wang, Aoli
Zou, Fengming
Liu, Qingwang
Liu, Juan
Wang, Wenliang
Hu, Chen
Chen, Yongfei
Wang, Zuowei
Wang, Beilei
Wang, Li
Liu, Jing
Liu, Qingsong
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15170 - 15188
[8] Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in High Grade Neuroendocrine Tumors in the Gastrointestinal Tract
Qin, J.
Zhang, X.
Gupta, R.
LABORATORY INVESTIGATION, 2014, 94 : 198A - 198A
[9] Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in High Grade Neuroendocrine Tumors in the Gastrointestinal Tract
Qin, J.
Zhang, X.
Gupta, R.
MODERN PATHOLOGY, 2014, 27 : 198A - 198A
[10] Differential Expression of Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Enhancer of Zeste Homolog 2 (EZH2) Protein-Positive T-Cell Neoplasms
Tian, Xuejun
Shahsafaei, Ali
Pelton, Ashley
Unitt, Christine
Dorfman, David M.
LABORATORY INVESTIGATION, 2017, 97 : 381A - 381A

← 1 2 3 4 5 →